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Abstract: 
Enteroviruses and Parechoviruses are increasingly recognized as the cause of aseptic meningitis, especially in the 
paediatric age group. However, because of indistinguishable clinical features with bacterial meningitis, many 
clinicians cannot make a clear distinction in disease presentation, and a large number of cases go undiagnosed. 
Although polymerase chain reaction is the current standard diagnostic approach, it takes many hours or days to get 
a result and these tests are not available at primary and secondary levels of care in many resource-poor countries. 
Furthermore, diagnosis is often difficult in children due to nonspecific cellular and biochemical cerebrospinal fluid 
findings. Some affected children may develop neurologic or/and systemic complications, resulting in prolonged 
hospital admission, increasing the risk of avoidable deaths, and healthcare expenditures. This review focuses on 
epidemiology, presentation, and diagnosis of Enterovirus and Parechovirus meningitis, highlighting the challenges in 
diagnosis and the potential roles of on-site CSF virology tests in improving the quality of paediatric patient’s care. 
The information provided should help early case detection, thereby ensuring avoidance of unnecessary antibiotics, 
minimal complications, a short period of hospital stays, and a reduction in healthcare-associated costs. 
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Abstrait: 
Les entérovirus et les parechovirus sont de plus en plus reconnus comme la cause de la méningite aseptique, en 
particulier dans le groupe d'âge pédiatrique. Cependant, en raison des caractéristiques cliniques indiscernables de la 
méningite bactérienne, de nombreux cliniciens ne peuvent pas faire une distinction claire dans la présentation de la 
maladie, et un grand nombre de cas ne sont pas diagnostiqués. Bien que la réaction en chaîne par polymérase soit 
l'approche diagnostique standard actuelle, il faut plusieurs heures ou jours pour obtenir un résultat et ces tests ne 
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sont pas disponibles aux niveaux de soins primaires et secondaires dans de nombreux pays pauvres en ressources. 
En outre, le diagnostic est souvent difficile chez les enfants en raison de découvertes non spécifiques du liquide 
céphalo-rachidien cellulaire et biochimique. Certains enfants atteints peuvent développer des complications 
neurologiques ou systémiques, entraînant une hospitalisation prolongée, augmentant le risque de décès évitables et 
les dépenses de santé. Cette revue se concentre sur l'épidémiologie, la présentation et le diagnostic de la méningite 
à entérovirus et parechovirus, mettant en évidence les défis du diagnostic et les rôles potentiels des tests 
virologiques sur place dans le LCR dans l'amélioration de la qualité des soins aux patients pédiatriques. Les 
informations fournies devraient contribuer à la détection précoce des cas, garantissant ainsi d'éviter les 
antibiotiques inutiles, des complications minimales, une courte période d'hospitalisation et une réduction des coûts 
associés aux soins de santé. 
Mots clés: méningite aseptique; Entérovirus; Parechovirus; Défi diagnostique; Test de virologie sur place; Enfants 
Introduction: 
 
 Despite advances in antimicrobials, 
infections of the central nervous system (CNS) 
remain a major cause of many life-threatening 
disease conditions, with aseptic meningitis at 
the forefront, especially in the paediatric age 
group. Aseptic meningitis (AM) is an acute inf-
lammation of meninges of the brain and spinal 
cord in which the cerebrospinal fluid (CSF) is 
negative for bacteria (1). AM is specifically 
caused by Enteroviruses (EVs) and Parecho- 
viruses (PeVs), however, viruses such as 
Herpes simplex virus types I & II (HSV I & II), 
Varicella zoster virus (VZV), Adenovirus (ADV), 
Rhinovirus (RHV), Epstein Barr virus (EBV), 
Cytomegalovirus (CMV), Mumps virus, Human 
herpesvirus 6 (HHV 6) and HIV have been 
implicated (2-11). Also, there are non-viral 
causes such as drugs (12-14), parasites, fungi, 
and inflammatory diseases (7-9). EBV and 
Cryptococcus are recovered mostly in immuno-
compromised individuals (9).   
 EVs and PeVs are emerging pathogens 
that constitute two important genera (Entero 
virus and Parechovirus) of the Picornaviridae 
family. The family of picornaviruses consists 
small (≈30nm), non-enveloped viruses con- 
taining single-stranded, linear, positive-sense 
RNA, with several important human and animal 
pathogens including Polio viruses (15,16). 
Enterovirus genus consists of 15 species [EV: 
(A-L) and Rhinovirus (RV: A-C)], and over 100 
serotypes have been described (17,18). The 
genus Parechovirus contains four species; 
Parechovirus A, formally Human Parechovirus 
(HPeV), Parechovirus B (formerly Ljungan virus 
infecting rodents), Parechovirus C (Sebokele 
virus), and Parechovirus D (Ferret Parecho- 
virus). Nineteen different genotypes of PeV-A 
have so far been described and their count is 
still on the increase (16,19-21).  
 Because of their pathogenic potential, 
increasing frequency of detection (even among 
healthy individuals), and the ability to cause 
severe infections, EVs and PeVs attracted more 
attention and became relevant globally (19-
27). But, without clear distinction in clinical 
presentation and non-specific CSF findings, 
diagnosis of AM is rarely considered, and only 
when the first line of care (usually antibiotic 
therapy) fails (28-32). The situation is worse- 
ning in countries with poor laboratory diag- 
nostic services and inadequate intensive care 
facilities.  
 The on-site CSF virology tests elimi- 
nate the technicalities of sample preparation 
and processing and produce results in a matter 
of minutes. They offer a superior advantage in 
patients’ management through early recog- 
nition of cases and exclusion of other sus- 
pected pathogens. Reduction in the use of 
unnecessary antibiotics, expendable costly inv- 
estigations, as well as guiding investigations 
and follow-up for potential complications in 
severely affected children are among added 
benefits (29,31,33). In this review, we pro- 
vided a summary of current knowledge on 
Enterovirus and Parechovirus meningitis, with 




 This article is a narrative review of 
Enterovirus and Parechovirus meningitis avai- 
lable in the literature. Original and review 
articles published in English Language were 
searched for on PubMed, Embase, Scopus, and 
Google Scholar. Articles reporting information 
relating to the biology and classification of 
Enterovirus and Parechovirus, epidemiology, 
clinical presentations, and laboratory diagnosis 
of meningitis caused by these viruses, as well 
as the diagnostic challenges, and the potential 
roles of on-site CSF virology tests were retri- 
eved and reviewed.  
 
Epidemiology of Enteroviruses and Parecho- 
viruses  
 Human EVs and PeV-A are ubiquitous, 
transmitted mainly by direct contact with res- 
piratory secretions, droplets, nasal discharge, 
sputum, saliva, or faeces, from symptomatic or 
asymptomatic carriers, within a family, in 
schools, hostels, and chronic care facilities (34-
39). Nosocomial (40,41), and transplacental 
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transmission (24,42) have been reported. They 
cause several diseases in humans (sporadic 
and endemic) and have the potential for pan- 
demic spread (25,43,44). However, the exact 
disease incidence is not known. Reports vary 
by country, demographic characteristics, and 
virus genotype. EVs typically infects older 
children and adults while the PeVs predominate 
in neonates and infants (20,21,31,38,45-52). 
A pooled-data from Japan, Hong Kong, Den- 
mark, Finland, Netherlands, the USA, and 
Malawi revealed a prevalence of ≈ 2% for PeV-
A in children with suspected viral infections 
(35,44,52). In under-developed nations, data 
are limited because the diagnostic facilities are 
difficult to operationalize and only restricted to 
referral laboratories. In tropical Africa, reliable 
data are only available in countries with good 
research-link (9,18,19,30,36,39,52-59).  
 From a recent study in the UK and the 
Republic of Ireland, the incidence of EV-PeV 
meningitis was twice that of bacterial mening- 
itis (24). AM is more prevalent during the hot 
season, usually May to September (10,24,60-
63), but can occur all-year-round (10,49, 
56,63-67). Cases are seen mostly in children 
less than five years of age (50,63), more 
males affected than females, and there may be 
variation in the distribution (30,55,62,63,65). 
The infection accounts for many admissions 
into intensive care units, with associated 
mortality (11,24,29,49,61,68-70). The summary 
of the detection rates from various countries is 
shown in Table 1. 
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 Socio-demographic factors such as 
age, gender, season, and study design accoun- 
ted for substantial disparity in disease pre- 
valence, in countries, and regions within the 
same country, with studies mostly on EVs. 
Estimates indicated variation in peak age of 
the infection, but mostly within the first five 
years of life (≤5 years for EVs versus <3 
months for PeVs). It is important to note that 
symptoms in neonates are subtle and not 
different from sepsis-like illnesses, which leads 
to a serious challenge in diagnosis and repor- 
ting, suggesting the need for high-quality sur- 
veillance to optimize detection, as country-
specific estimates are crucial tools to improve 
diagnostics and therapeutics for these infec- 
tions.  
 
Prevailing genotypes/serotypes of EVs and 
PeVs involved in AM and other infections 
 On specific serotypes, Coxsackievirus 
B5 (CVB5), Coxsackievirus A9 (CVA9), Echo- 
virus 6, 9, and 30 and CVB3 are the most 
commonly reported serotypes from AM and 
other clinical infections (49,55,63,64,71-78). 
Other serotypes recovered include Echovirus 1, 
3, 4, 5, 7, 11, 13-16, 18, 20, 25, 27, 32 and 
33; CVB1, CVB2, CVB4, CVB6; CVA2, CVA4-6, 
CVA10, CVA15, CVA16, CVA21 and EV71 (6, 
10,28,45,49,55,56,60-67,71-73,75,76,79-89). 
On the other hand, PeV-A3 is the mostly 
recovered genotype (31,47-50,60,90,91) while 
other genotypes recovered are PeV-A 2 and 1 
(47,92).  
 
Clinical presentations of meningitis caused by 
EVs and PeVs and complications  
 Usually, there is no clear distinction in 
clinical presentations of meningitis caused by 
EV, PeV, or bacteria agents. Fever is the most 
common symptom and is usually moderate to 
high grade. Nausea, vomiting, diarrhea, poor 
feeding, irritability, convulsions, headache, and 
altered level of consciousness are notable sym- 
ptoms (24,31,56,60-64,71,77,82,93-95). Head- 
ache, vomiting, neck rigidity, and lethargy are 
pronounced in children with EV meningitis (77, 
94,96). Patients may present with typical 
features of upper respiratory tract infections, 
and maculopapular rashes mostly in those with 
PeV infections (31,60,97).  
 The severity and risk of developing 
complications depend on the virus type, 
patient age, and the interval between disease 
onset and presentation to the physician (31, 
32,94,98,99). Abnormalities of the white 
matter and neurodevelopmental delays are the 
common sequelae (24,31,32,47,50,51,91,98, 
100,101). Subdural hemorrhage, coronal inf- 
artion, cystic encephalomalacia, periventricular 
leukomalacia, and ventricular dilatations are 
specific complications. Such patients may 
manifest with failure to thrive (FTT), recurrent 
seizures, visual impairment, and global hypo- 
tonia (11,24,31,49,91,102). Hyponatremia due 
to the syndrome of inappropriate antidiuretic 
hormone secretion (SIADS) has been reported 
(70). Shaker and Abdelhamid reported 50% 
mortality in patients who tested positive for EV 
(30), while some other studies also reported 
considerable mortalities (24,31,70).    
 
Laboratory diagnosis of EVs/PeVs infections 
and challenges 
 Laboratory testing is essential for the 
definitive diagnosis of infectious meningitis, 
particularly in the young infant, because 
clinical disease presentation lacks predictive 
value. CSF pleocytosis and elevated protein are 
the recommended criteria for diagnosis, how- 
ever, many studies showed varied results (10, 
24,28-32,56,60,73,75,88,91). With contradict- 
tory reports of other markers such as C-reac- 
tive protein (CRP), lactate, mononuclear, or 
polymorphonuclear cells counts (24,91,103, 
104), there could be uncertainty in diagnosis 
and treatment. Therefore, it should be noted 
that with the positive signs and symptoms of 
meningitis, the absence of CSF pleocytosis, 
elevated protein, or other markers of interest 
does not rule out EV or PeV meningitis.  
 The mainstay of the diagnosis is mole- 
cular-based assays on appropriately collected-
samples. Cell culture is one of the most 
popular methods for virus isolation, evidenced 
by the cytopathic effect (CPE), which alter 
specific characteristics of the cells. However, 
cultures are intensive and some viruses (most 
especially PeVs) do not replicate in commonly 
used cell lines. Thus, researchers nowadays 
are reluctant to use cultures and tend to adopt 
PCR techniques for relative simplicity and short 
window for results (21,23). Recently, we eva- 
luated the diagnostic sensitivity of cell culture, 
real time RT PCR, and nested RT PCR for EVs 
and PeVs, and real time RT PCR demonstrated 
the highest sensitivity and negative predictive 
value (NPV), particularly for EVs (unpublish 
work). Specifically, real-time PCR is the reco- 
mmended test for EVs and PeVs in all clinical 
specimens (21,23). The PCR assay relies on 
the extraction and purification of nucleic acid, 
then exponential amplification of the target 
sequence, using a thermostable polymerase 
and specific primers.   
 Unfortunately, most tropical and sub-
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tropical countries cannot establish qualitative 
molecular-based diagnostic tests in basic 
healthcare settings. This contributes to the 
enormous burden of ill health as infectious 
diseases represent the major cause of death in 
most of the countries. Another fundamental 
problem is the lack of incorporation of EVs and 
PeVs among the list of priority infections. This 
significantly deterred identification of the path- 
ogens even in developed nations. Therefore, 
misdiagnosis and failure to treat a serious 
infection or wasting expensive treatment on 
those not infected remain a serious obstacle. 
Even without targeted treatment, early identi- 
fication of infections has economic benefits, 
which include stopping the use of unnecessary 
antimicrobial drugs, minimizing expendable 
investigations, and shortening the length of 
hospital admissions (24,105,106).  
 
On-site CSF virology tests and management of 
EV and PeV infections 
 The WHO has established the 
ASSURED (Affordable, Sensitive, Specific, User 
friendly, Rapid, and robust, Equipment-free, 
and Deliverable to end-users) criteria (107) for 
diagnostics in a resource-poor setting. This 
aimed at providing better management of 
diseases through immediate delivery of results 
and a rapid record of the disease status, 
improve clinical decision-making. The cost-
effective on-site CSF virology tests employ 
reverse-transcriptase polymerase chain reac- 
tion to rapidly identify the presence of viral 
RNA in CSF of a suspected infected individual. 
These offer superior advantages over conven- 
tional nested PCR and real-time PCR by 
providing prompt identification of the path- 
ogen, guide selection of therapy, and minimize 
complications. Added advantages include short 
time window for results (rapid turnaround 
time), antimicrobial stewardship through app- 
ropriate prescribing practice, reduction in 
financial costs, and improve patient outcomes 
(8,9,108-114). Additionally, the WHO recom- 
mended criteria of the physical structure and 
human resources as key elements of a virology 
laboratory (115) can be adjusted to suit the 
desired need in a particular setting, hence, 
guaranteeing the feasibility of carrying out 
these tests in most of our local clinics and 
hospitals.  
 Currently, there are no antiviral agents 
licensed for the treatment of EVs and PeVs 
infections, but vaccines are available only 
against PVs, and China licensed an EV71 
vaccine in December 2015 (116). Researchers 
are currently exploring the potential benefits of 
intravenous immunoglobulins (IVIGs), predni- 
solone, and other compounds in the mana- 
gement of EVs and PeVs infections. Of recent, 
a compound 2′-C-methylcytidine, an inhibitor 
of viral polymerase, demonstrated promising 




 Enteroviruses and Parechoviruses are 
the leading causes of aseptic meningitis, and 
there exist indistinguishable presentations with 
bacterial meningitis, while CSF pleocytosis and 
biochemical tests show limited roles in 
diagnosis. The disease prevalence varies in 
different geographical regions, mainly affected 
by socio-demographic factors, and E9, 30, 6, 
16, CVB5, CVA9, CVB3, and PeV-A3 are 
commonly isolated virus serotypes. Although 
the WHO recommends syndromic management 
in settings with limited access to laboratory 
diagnostic services, the economic burden of 
treating common causes of the syndrome is 
outrageous and merely impossible in local 
settings. With the evolution of high precision 
point-of-care CSF virology tests, stockholders 
should explore their benefits to optimize the 
quality of care in children with EVs and PeVs 
meningitis, most especially in resource-poor 
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